Giovanni Ucci

TL;DR: Patients with leukemia, refractory anemia, multiple myeloma, and brain and gastric tumors are studied and data indicate that in vivo BrdUrd infusion coupled with flow cytometry measurements can be performed in clinical settings and that this method is reliable.

TL;DR: In the most recently diagnosed patients, the percentage of those who had symptoms related to multiple myeloma (i.e. any of bone pain, systemic symptoms, disturbances related to hypercalcemia, neurological involvement and hyperviscosity) was reduced and systemic symptoms were reported more seldom, indicating that multipleMyeloma is diagnosed earlier now than in the past.

TL;DR: A more intensive regimen failed to show any benefit in disease-free and OS versus monotherapy, and a sequential treatment of FOLFIRI followed by docetaxel plus cisplatin improves disease- free survival in comparison with 5-FU/LV in patients with radically resected gastric cancer.

TL;DR: The possibility of improving the prognostic forecast in MM is explored by considering some clinical characteristics at diagnosis together with response to first-line chemotherapy, and a scoring system able to identify three different risk classes is proposed.

TL;DR: Adult patients with non-lymphoblastic acute leukaemia had pretreatment proliferative activity of bone marrow blasts determined simultaneously with propidium iodide DNA flow cytofluorometry and in vitro tritiated thymidine cytoautoradiography, indicating that 2n-4n cell % is a statistically significant independent factor correlating with duration of response in adult AnLL.